63 related articles for article (PubMed ID: 7680159)
21. Hepatitis C virus in renal transplantation.
Oliveras A; Lloveras J; Puig JM; Comerma I; Bruguera M; Barrera J; Mir M; Aubia J; Masramon J
Transplant Proc; 1991 Oct; 23(5):2636-7. PubMed ID: 1926513
[No Abstract] [Full Text] [Related]
22. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
[TBL] [Abstract][Full Text] [Related]
23. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients.
Glicklich D; Thung SN; Kapoian T; Tellis V; Reinus JF
Am J Gastroenterol; 1999 Jan; 94(1):159-63. PubMed ID: 9934748
[TBL] [Abstract][Full Text] [Related]
24. Liver histology in renal transplant patients after more than 10 years of hepatitis C virus infection.
Rostaing L; Rumeau JL; Cisterne JM; Izopet J; Chabannier MH; Durand D
Transplant Proc; 1996 Oct; 28(5):2836-7. PubMed ID: 8908089
[No Abstract] [Full Text] [Related]
25. [When should hepatitis C serology be required in dermatology?].
Dupin N; Chosidow O; Lunel F; Francès C
Ann Dermatol Venereol; 1994; 121(8):574-8. PubMed ID: 7538742
[No Abstract] [Full Text] [Related]
26. Analysis of serum ferritin changes after kidney transplantation: a prospective study of 123 cases.
Lataste A; Renoult E; Lederlin P; Kessler M
Transplant Proc; 1994 Aug; 26(4):2001-5. PubMed ID: 7520618
[No Abstract] [Full Text] [Related]
27. Liver function tests in hepatitis C virus infected kidney transplant recipients.
Manfro RC; Karohl C; Goncalves LF; Senger MB; Thomé FS; Prompt CA
Transplant Proc; 1995 Apr; 27(2):1821-2. PubMed ID: 7725519
[No Abstract] [Full Text] [Related]
28. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
Amiri ZM; Shakib AJ; Toorchi M
East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
[TBL] [Abstract][Full Text] [Related]
29. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection.
Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S
East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
[TBL] [Abstract][Full Text] [Related]
31. Clinical implication of the presence of hepatitis C virus antibodies after kidney transplantation in Japan.
Tomikawa S; Ito S; Kikuchi K; Ando Y; Ichikawa N; Meigata K; Nomura Y; Watanabe K; Degawa H; Beck Y; Nagao T; Uchida H
Transplant Proc; 1996 Jun; 28(3):1498-500. PubMed ID: 8658758
[No Abstract] [Full Text] [Related]
32. Impact of presence of HBs antigen and anti-hepatitis C virus and anti-cytomegalovirus antibodies on transplanted kidney survival.
Sieńko J; Wiśniewska M; Ciechanowski K; Rózański J; Domański L; Myslak M; Kamiński M; Sulikowski T; Pabisiak K; Romanowski M; Mizerski A; Tejchman K; Nowacki M; Ostrowski M; Bohatyrewicz R
Transplant Proc; 2006; 38(1):136-8. PubMed ID: 16504685
[TBL] [Abstract][Full Text] [Related]
33. Impact of HCV infection on first cadaveric renal transplantation, a single center experience.
Lin HH; Huang CC; Huang JY; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
Clin Transplant; 2004 Jun; 18(3):261-6. PubMed ID: 15142046
[TBL] [Abstract][Full Text] [Related]
34. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
[TBL] [Abstract][Full Text] [Related]
35. Anti-hepatitis G E2 antibody detection and its relation to serum HGV-RNA in patients with clotting disorders: high prevalence of HGV infection and spontaneous remission.
Sheng L; Soumillion A; Peerlinck K; Verslype C; Schelstraete R; Gyselinck F; Emonds MP; Hess G; Vermylen J; Desmyter J; Yap SH
Thromb Haemost; 1998 Apr; 79(4):752-5. PubMed ID: 9569187
[TBL] [Abstract][Full Text] [Related]
36. Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience.
del Pozo AC; Martín JD; Rodriguez-Laiz G; Sturdevant M; Iyer K; Schwartz M; Schiano T; Lerner S; Ames S; Bromberg J; Thung S; de Boccardo G
Transplant Proc; 2009 Jun; 41(5):1713-6. PubMed ID: 19545713
[TBL] [Abstract][Full Text] [Related]
37. Clinical course of hepatitis C virus infection in renal transplant recipients.
Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus antibody in alcoholic patients. Association with the presence of portal and/or lobular hepatitis.
Rosman AS; Paronetto F; Galvin K; Williams RJ; Lieber CS
Arch Intern Med; 1993 Apr; 153(8):965-9. PubMed ID: 7683191
[TBL] [Abstract][Full Text] [Related]
39. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and seroconversion to HCV in hemodialyzed patients, and epidemiological factors.
Morales MF; Lossi JS; Alderete TN; Noli D
Transplant Proc; 1996 Dec; 28(6):3402-5. PubMed ID: 8962329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
